The University of Chicago Header Logo

Connection

Jerry Krishnan to Muromonab-CD3

Back to Details
This is a "connection" page, showing publications Jerry Krishnan has written about Muromonab-CD3.
Jerry Krishnan
Connection Strength
0.052
Muromonab-CD3
  1. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant. 2001 Dec; 20(12):1282-90.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.